Your browser doesn't support javascript.
loading
The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy: A Population-Based Cohort Study.
Tryggvadottir, Helga; Sandén, Emma; Björner, Sofie; Bressan, Alessandra; Ygland Rödström, Maria; Khazaei, Somayeh; Edwards, Dean P; Nodin, Björn; Jirström, Karin; Isaksson, Karolin; Borgquist, Signe; Jernström, Helena.
Afiliação
  • Tryggvadottir H; Division of Oncology, Department of Clinical Sciences, Lund, Lund University and Skåne University Hospital, Lund, Sweden.
  • Sandén E; Division of Oncology, Department of Clinical Sciences, Lund, Lund University and Skåne University Hospital, Lund, Sweden.
  • Björner S; Division of Oncology, Department of Clinical Sciences, Lund, Lund University and Skåne University Hospital, Lund, Sweden.
  • Bressan A; Division of Oncology, Department of Clinical Sciences, Lund, Lund University and Skåne University Hospital, Lund, Sweden.
  • Ygland Rödström M; Division of Oncology, Department of Clinical Sciences, Lund, Lund University and Skåne University Hospital, Lund, Sweden.
  • Khazaei S; Division of Oncology, Department of Clinical Sciences, Lund, Lund University and Skåne University Hospital, Lund, Sweden.
  • Edwards DP; Department of Molecular & Cellular Biology and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, United States.
  • Nodin B; Division of Oncology and Therapeutic Pathology, Department of Clinical Sciences, Lund, Lund University and Skåne University Hospital, Lund, Sweden.
  • Jirström K; Division of Oncology and Therapeutic Pathology, Department of Clinical Sciences, Lund, Lund University and Skåne University Hospital, Lund, Sweden.
  • Isaksson K; Division of Surgery, Department of Clinical Sciences, Lund, Lund University, Lund, Sweden.
  • Borgquist S; Department of Surgery, Kristianstad Hospital, Kristianstad, Sweden.
  • Jernström H; Division of Oncology, Department of Clinical Sciences, Lund, Lund University and Skåne University Hospital, Lund, Sweden.
Front Oncol ; 11: 642768, 2021.
Article em En | MEDLINE | ID: mdl-34094928

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia